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Regardless of species, all the living organisms have poly-
saccharides called glycans in their cellular surfaces or
even inside the cells. Glycans interact with sugar-binding
proteins, lectin, and affects on the numerous biological
activities such as development, immune response, orga-
nogenesis or even cancer development. Although there
are many reports on the expressional disorders of lectins
or glycans in cancer cells, most of them have described
only single or few gene product’s aberrations.
Here we describe the application of a novel lectin micro-
array system (LecMS), which consists of 45 lectins with
different binding preferences and provides the multiple
glycan-lectin binding intensity information, on various leu-
kemic cell lines.
As we carry the endemic areas of Adult T-cell Leuke-
mia (ATL), which is caused by an infection of retrovirus
(HTLV-1), our interest was focused on how this system
characterize the ATL or non-ATL cells by their lectin-
glycan binding intensity (LGI) values.
From the results of LecMS profiling on thirteen differ-
ent ATL or non-ATL tumor cells, we found LGI values
which are commonly induced in all tumor cells and
values induced specifically in ATL cells, respectively.
Furthermore, we found these LGI values change with
anti-cancer drug administration and the changing pat-
terns varies with cell lines. High-throughput, sensitive
and relatively simple nature of this system could be uti-
lized as the novel profiling tool for the prognosis of
ATL.
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